These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 12566663)

  • 1. Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood.
    Tullis RH; Duffin RP; Zech M; Ambrus JL
    Blood Purif; 2003; 21(1):58-63. PubMed ID: 12566663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical model of the effect of affinity hemodialysis on the T-cell depletion leading to AIDS.
    Tullis RH
    Blood Purif; 2004; 22(1):84-91. PubMed ID: 14732816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity hemodialysis for antiviral therapy. I. Removal of HIV-1 from cell culture supernatants, plasma, and blood.
    Tullis RH; Duffin RP; Zech M; Ambrus JL
    Ther Apher; 2002 Jun; 6(3):213-20. PubMed ID: 12109946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
    Herbeuval JP; Shearer GM
    AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells.
    Du SX; Xu L; Viswanathan S; Whalen RG
    Protein Expr Purif; 2008 Jun; 59(2):223-31. PubMed ID: 18406166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.
    Clayton R; Ohagen A; Goethals O; Smets A; Van Loock M; Michiels L; Kennedy-Johnston E; Cunningham M; Jiang H; Bola S; Gutshall L; Gunn G; Del Vecchio A; Sarisky R; Hallenberger S; Hertogs K
    J Virol Methods; 2007 Jan; 139(1):17-23. PubMed ID: 17034868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.
    Masiero S; Del Vecchio C; Gavioli R; Mattiuzzo G; Cusi MG; Micheli L; Gennari F; Siccardi A; Marasco WA; Palù G; Parolin C
    Gene Ther; 2005 Feb; 12(4):299-310. PubMed ID: 15496956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
    Roda Rani KP; Pelluru D; Kondapi AK
    Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
    Williamson MP; McCormick TG; Nance CL; Shearer WT
    J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
    Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
    J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody hNM01 in HIV-infected patients: a phase I study.
    Dezube BJ; Doweiko JP; Proper JA; Conway B; Hwang L; Terada M; Leece BA; Ohno T; Mastico RA
    J Clin Virol; 2004 Dec; 31 Suppl 1():S45-7. PubMed ID: 15567093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation.
    Gibellini D; De Crignis E; Ponti C; Cimatti L; Borderi M; Tschon M; Giardino R; Re MC
    J Med Virol; 2008 Sep; 80(9):1507-14. PubMed ID: 18649336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects?
    Klasse PJ; Moore JP
    Virology; 2004 May; 323(1):1-8. PubMed ID: 15165814
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.
    Höhn H; Kortsik C; Tully G; Nilges K; Necker A; Freitag K; Neukirch C; Galle P; Löhr H; Maeurer MJ
    Eur J Immunol; 2003 Jun; 33(6):1613-23. PubMed ID: 12778479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.
    Johansson S; Goldenberg DM; Griffiths GL; Wahren B; Hinkula J
    AIDS; 2006 Oct; 20(15):1911-5. PubMed ID: 16988511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection.
    Heggelund L; Mollnes TE; Espevik T; Müller F; Kristiansen KI; Aukrust P; Frøland SS
    Eur J Clin Invest; 2005 Dec; 35(12):765-70. PubMed ID: 16313253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.